Publicaciones en colaboración con investigadores/as de King's College London (15)

2024

  1. Multivariable prediction of functional outcome after first-episode psychosis: a crossover validation approach in EUFEST and PSYSCAN

    Schizophrenia, Vol. 10, Núm. 1

  2. Public perception of psychiatry, psychology and mental health professionals: a 15-year analysis

    Frontiers in Psychiatry, Vol. 15

2023

  1. Dramatic increase of suicidality in children and adolescents after COVID-19 pandemic start: A two-year longitudinal study

    Journal of Psychiatric Research, Vol. 163, pp. 63-67

  2. Negative symptoms in First-Episode Schizophrenia related to morphometric alterations in orbitofrontal and superior temporal cortex: The OPTiMiSE study

    Psychological Medicine, Vol. 53, Núm. 8, pp. 3471-3479

  3. Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosis

    Acta Psychiatrica Scandinavica

  4. Structural covariance predictors of clinical improvement at 2-year follow-up in first-episode psychosis

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 120

2022

  1. Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis

    Schizophrenia, Vol. 8, Núm. 1

  2. Corrigendum to “What about mental health after one year of COVID-19 pandemic? A comparison with the initial peak” [J. Psychiatr. Res. 153 (2022) 104–108, (S0022395622003764), (10.1016/j.jpsychires.2022.07.010)]

    Journal of Psychiatric Research

  3. What about mental health after one year of COVID-19 pandemic? A comparison with the initial peak

    Journal of Psychiatric Research, Vol. 153, pp. 104-108

2021

  1. Symptom Remission and Brain Cortical Networks at First Clinical Presentation of Psychosis: The OPTiMiSE Study

    Schizophrenia bulletin, Vol. 47, Núm. 2, pp. 444-455

2020

  1. Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning

    European Neuropsychopharmacology, Vol. 34, pp. 76-86

2019

  1. Computerized cognitive remediation therapy, REHACOM, in first episode of schizophrenia: A randomized controlled trial

    Psychiatry Research, Vol. 281

2018

  1. Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

    The Lancet Psychiatry, Vol. 5, Núm. 10, pp. 797-807

2014

  1. Estudio farmacogenético del tratamiento a largo plazo con antipsicóticos de segunda generación y sus efectos adversos metabólicos (Estudio SLiM): justificación, objetivos, diseño y descripción de la muestra

    Revista de Psiquiatria y Salud Mental, Vol. 7, Núm. 4, pp. 166-178

  2. Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case-control sample from Spain

    Schizophrenia Research, Vol. 159, Núm. 1, pp. 107-113